羚锐制药：上半年业绩亮眼，核心竞争力持续凸显
Lingrui Pharma(600285) 华安证券·2024-08-13 23:30羚[Ta锐ble制_Sto药ckN（ameRptType] 600285） 公司点评 | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------|--------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...